Letsiou Sophia, Nischwitz Volker, Traar Pedro, Francesconi Kevin A, Pergantis Spiros A
University of Crete, Department of Chemistry, Environmental Chemical Processes Laboratory, Voutes, Heraklion 71003, Crete, Greece.
Rapid Commun Mass Spectrom. 2007;21(3):343-51. doi: 10.1002/rcm.2843.
The narrow gap between essentiality and toxicity of selenium requires detailed investigations on selenium metabolism in order to find suitable indicators for the selenium status in the human body. Current methods for quantitative selenium speciation in human urine are based on separation by high-performance liquid chromatography (HPLC) coupled online with elemental mass spectrometry (MS), and the potential of molecular MS detection techniques for the reliable identification and quantification of selenosugars in crude human urine has not been utilized. Now we report the development of an HPLC tandem mass spectrometric (MS/MS) method for the reliable determination in crude human urine of three significant selenium urinary metabolites, collectively termed selenosugars, namely methyl 2-acetamido-2-deoxy-1-seleno-beta-D-galactopyranoside (SeGalNAc), methyl 2-acetamido-2-deoxy-1-seleno-beta-D-glucopyranoside (SeGluNAc) and methyl 2-amino-2-deoxy-1-seleno-beta-D-galactopyranoside (SeGalNH2). Reversed-phase HPLC, with and without cation-exchange guard columns, was applied for the separation of the selenosugars, and atmospheric pressure chemical ionization (APCI) and selected reaction monitoring (SRM) were used for selective and sensitive detection. The collision-induced dissociation behaviour of the selenosugars was studied in detail using APCI triple quadrupole MS/MS and electrospray ion trap MS. The developed method was applied to urine samples collected prior to and after selenium supplementation for the quantification of SeGalNAc using both external calibration and the method of standard additions. Additionally, SeGalNH2 was detected in urine samples after Se supplementation. Finally, neutral loss scanning was explored as a possible method for the detection of unknown methyl-selenosugars.
硒的必需性与毒性之间的差距很小,这就需要对硒的代谢进行详细研究,以便找到适合人体硒状态的指标。目前用于定量分析人尿中硒形态的方法是基于高效液相色谱(HPLC)与元素质谱(MS)在线联用,而尚未利用分子质谱检测技术可靠鉴定和定量粗制人尿中硒糖的潜力。现在我们报告一种HPLC串联质谱(MS/MS)方法的开发,该方法可可靠地测定粗制人尿中三种重要的硒尿代谢物,统称为硒糖,即甲基2-乙酰氨基-2-脱氧-1-硒代-β-D-吡喃半乳糖苷(SeGalNAc)、甲基2-乙酰氨基-2-脱氧-1-硒代-β-D-吡喃葡萄糖苷(SeGluNAc)和甲基2-氨基-2-脱氧-1-硒代-β-D-吡喃半乳糖苷(SeGalNH2)。采用带有和不带有阳离子交换保护柱的反相HPLC分离硒糖,并使用大气压化学电离(APCI)和选择反应监测(SRM)进行选择性和灵敏检测。使用APCI三重四极杆MS/MS和电喷雾离子阱MS详细研究了硒糖的碰撞诱导解离行为。所开发的方法应用于补充硒前后收集的尿样,采用外标法和标准加入法对SeGalNAc进行定量。此外,在补充硒后的尿样中检测到了SeGalNH2。最后,探索了中性丢失扫描作为检测未知甲基硒糖的一种可能方法。